TABLE 3.
All (n = 625) |
Type 2 diabetes (n = 178) |
SOD (n = 447) |
||||
β | p | β | p | β | P | |
Fasting glucose, mg/dL | 0.11(0.2−2.4) | 0.02a† | 0.30(2.5−9.2) | < 0.001b € | −0.06(−1.2−0.3) | 0.27 |
HbA1c,% | −0.02(−0.2−0.2) | 0.80 | −0.02(−0.3−0.3) | 0.85 | −0.02(−0.2−0.2) | 0.86 |
Total cholesterol, mg/dL | −0.03(−0.9−4.6) | 0.53 | −0.08(−1.5−1.4) | 0.93 | −0.04(−1.0−0.5) | 0.52 |
HDL-c, mg/dL | −0.08(−0.1−0.2) | 0.10 | −0.02(0.4−0.3) | 0.80 | −0.11(−1.0−0.02) | 0.06 |
LDL-c, mg/dL | −0.07(−2.6−0.4) | 0.15 | −0.08(−3.8−1.5) | 0.39 | −0.06(−2.8−0.85) | 0.62 |
Triglycerides, mg/dL | 0.09(0.1−5.9) | 0.04c ‡ | 0.22(1.6−14.4) | 0.01d € | 0.03(−2.3−4.3) | 0.56 |
Systolic BP, mm Hg | −0.01(−0.2−0.2) | 0.74 | −0.09(−3.3−0.9) | 0.83 | −0.09(−1.8−0.1) | 0.10 |
Diastolic BP, mm Hg | −0.06(−0.07−0.2) | 0.27 | −0.14(−2.6−0.1) | 0.08 | −0.03(−1.0−0.5) | 0.47 |
Variables correlated on Pearson or Spearman correlation (r > 0.20) were subjected to stepwise multivariate linear regression. aMultivariate linear regression analysis adjusted for age, sex, BMI, menopause status, time since diagnosis of type 2 diabetes, use of sleeping pills and total calories consumed after 9:00 p.m. bMultivariate linear regression analysis adjusted for age, sex, BMI, time since diagnosis of type 2 diabetes, menopause status and total calories consumed after 9:00 p.m. cMultivariate linear regression analysis adjusted for age, sex, time since diagnosis of dyslipidemia, and total calories consumed after 9:00 p.m. dMultivariate linear regression analysis adjusted for age, sex, BMI, time since diagnosis of dyslipidemia, menopause status and minutes of physical activity per week. †r2 adjusted = 0.04. €r2 adjusted = 0.07. ‡r2 adjusted = 0.02. SOD, systemic arterial hypertension and/or obesity and/or dyslipidemia group; HbA1c, glycated hemoglobin.